サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1741163

配合化学療法市場：薬剤タイプ別、配合環境別、投与経路別、患者タイプ別、がんタイプ別、流通チャネル別、配合方法別、包装タイプ別、規制対応別、地域別

Compounding Chemotherapy Market, By Drug Type, By Compounding Setting, By Route of Administration, By Patient Type, By Cancer Type, By Distribution Channel, By Compounding Method, By Packaging Type, By Regulatory Compliance, By Geography

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.90円
配合化学療法市場：薬剤タイプ別、配合環境別、投与経路別、患者タイプ別、がんタイプ別、流通チャネル別、配合方法別、包装タイプ別、規制対応別、地域別
出版日: 2025年03月26日
発行: Coherent Market Insights
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

配合化学療法市場は、2025年には58億2,000万米ドルと推定され、2032年には81億3,000万米ドルに達すると予測され、2025～2032年までの年間平均成長率（CAGR）は4.9%で成長する見込みです。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 58億2,000万米ドル
実績データ 2020～2024年 予測期間 2025～2032年
予測期間：2025～2032年のCAGR 4.90% 2032年の金額予測 81億3,000万米ドル

配合化学療法とは、医薬品成分を個々の患者のニーズに合わせて薬にカスタマイズすることを指します。この背景には、世界のがん罹患率の上昇と特殊な薬剤製剤のニーズがあります。がん治療がより個別化されるにつれ、コンパウンドは患者に特定の疾患、状態、感受性に適した製剤を提供する上で重要な役割を果たしています。がんを発症しやすい高齢者の開発、精密医療と標的療法の重視の高まり、市販薬の不足は、配合化学療法サービスの採用を世界的に促進している主要因の一部です。

市場力学

がん、骨髄疾患、免疫系の問題などの疾病の有病率の増加は、予測期間中も世界の配合化学療法市場の成長を促進します。処方薬にかかる費用の増加や決済施策の変化は、予測期間にわたって世界の配合化学療法市場の成長を再び増大させると予想されます。製品による消費者の健康メリットの増加は、世界の配合化学療法市場に新たな機会を創出します。病院やヘルスケア産業では、配合化学療法による治療や医薬品に対する認識が高まっており、これも市場の拡大を後押ししています。

世界保健機関（WHO）によると、がんの罹患者数は2000年以降ほぼ倍増しており、今後20年間で70％以上の増加が見込まれています。個別化治療の選択肢や価値観による医療モデルに対する意識の高まりが、腫瘍科の開業医に調剤サービスの導入を促しています。また、特に小児がんに対する市販薬の不足は、この市場の参入企業に成長機会をもたらしています。しかし、汚染のリスク、複雑な製剤を調製する際の技術的課題、国によって一貫性のない規制環境が、市場拡大の妨げになる可能性もあります。薬局での調剤における3Dプリンティングの応用が拡大していることから、今後数年間でドラッグデリバリーの改善や個別化された投与設計が可能になり、新たな道が開かれる可能性が高いです。

本調査の主要特徴

  • 本レポートは、世界の調合化学療法市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模と複合年間成長率（CAGR%）を提供しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のコンパウンド化学療法市場の主要企業をプロファイルしています。
  • 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • コンパウンド化学療法の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業のさまざまな利害関係者を対象としています。
  • 利害関係者は、世界の配合化学療法市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
  • パーソナライズ医療の需要増加
  • がんなどの病気の罹患率の増加
    • 抑制要因
  • 化学療法剤の調合にかかる高コスト
    • 機会
  • 製品による消費者の健康メリットの増加
  • 影響分析
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • ポーター分析
  • 合併と買収のシナリオ

第4章 配合化学療法市場-コロナウイルス（COVID-19）パンデミックの影響

  • COVID-19疫学
  • 供給側と需要側の分析
  • 経済への影響

第5章 配合化学療法市場、薬剤タイプ別、2020～2032年

  • イントロダクション
  • 細胞傷害性薬剤
  • ホルモン剤
  • 免疫調節薬
  • 標的療法
  • 支持療法薬

第6章 配合化学療法市場、配合環境別、2020～2032年

  • イントロダクション
  • 病院調剤
  • 調剤薬局
  • 専門クリニック
  • 在宅ケア

第7章 配合化学療法市場、投与経路別、2020～2032年

  • イントロダクション
  • 静脈内（IV）
  • 経口
  • 皮下（SC）
  • 筋肉内（IM）
  • 脊髄内（IT）

第8章 配合化学療法市場、患者タイプ別、2020～2032年

  • イントロダクション
  • 成人患者
  • 小児患者
  • 高齢患者

第9章 配合化学療法市場、がんタイプ別、2020～2032年

  • イントロダクション
  • 乳がん
  • 肺がん
  • 大腸がん
  • 前立腺がん
  • 白血病
  • リンパ腫
  • その他の特定のがんタイプ

第10章 配合化学療法市場、流通チャネル別、2020～2032年

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第11章 配合化学療法市場、配合方法別、2020～2032年

  • イントロダクション
  • 無菌調合
  • 非無菌調合

第12章 配合化学療法市場、包装タイプ別、2020～2032年

  • イントロダクション
  • バイアル
  • アンプル
  • プレフィルドシリンジ
  • ボトル

第13章 配合化学療法市場、規制対応別、2020～2032年

  • イントロダクション
  • USP規制
  • FDA規制
  • EMA規制

第14章 配合化学療法市場、地域別、2020～2032年

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • ASEAN諸国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東
    • GCC諸国
    • イスラエル
    • その他の中東
  • アフリカ
    • 南アフリカ
    • 中央アフリカ
    • 北アフリカ

第15章 競合情勢

  • Braun Melsungen AG
  • Fagron NV
  • PharMEDium Services, LLC（AmerisourceBergen Corporation）
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Advanced Pharma, Inc.
  • McGuff Compounding Pharmacy Services, Inc.
  • Central Admixture Pharmacy Services, Inc.（CAPS）
  • Institutional Pharmacy Solutions, LLC
  • Wedgewood Pharmacy
  • Medisca Inc.
  • Dougherty's Holdings, Inc.
  • PharMEDium Services, LLC（AmerisourceBergen Corporation）
  • BioScrip, Inc.

第16章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI5892

Compounding Chemotherapy Market is estimated to be valued at USD 5.82 Bn in 2025 and is expected to reach USD 8.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.82 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.90% 2032 Value Projection: USD 8.13 Bn

Compounding chemotherapies refer to the customization of pharmaceutical ingredients into medication tailored to individual patient needs. This has been largely driven by the rise in cancer prevalence worldwide and the need for specialized drug formulations. As cancer treatments become more personalized, compounding plays a crucial role in providing patients with formulations suited to their specific disease, condition, or sensitivity. Growing geriatric population prone to developing cancers, increasing emphasis on precision medicine and targeted therapies, and shortages of commercially available drugs are some of the key factors fueling the adoption of compounding chemotherapy services globally.

Market Dynamics:

The increasing prevalence of illnesses like cancer, bone marrow conditions, and immune system problems will continue to fuel the growth of the global compounding chemotherapy market over the forecast period. Increasing costs for prescription drugs and changing payment policies are again expected to augment global compounding chemotherapy market growth over the forecast period. Rising consumer health benefits from the products will create new opportunities for the global compounding chemotherapy market. Hospitals and the healthcare industry are becoming more aware of compounded chemotherapy treatments or medicines, which is also assisting in the market's expansion.

According to the World Health Organization, the cancer burden has nearly doubled since 2000 and is expected to grow by over 70% in the next two decades. Increased awareness about personalized treatment options and value-based healthcare models is encouraging oncology practitioners to adopt compounding services. The shortage of commercially manufactured drugs, especially for pediatric cancer, also presents growth opportunities for players in this market. However, risks of contamination, technical challenges in preparing complex formulations, and an inconsistent regulatory environment across countries could hinder the market expansion to some extent. The growing application of 3D printing in pharmacy compounding is likely to open up new avenues, allowing for improved drug delivery and personalized dosage designs in the coming years.

Key features of the study:

  • This report provides in-depth analysis of the global compounding chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global compounding chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include B. Braun Melsungen AG, Fagron NV, PharMEDium Services, LLC (AmerisourceBergen Corporation), Baxter International Inc., Fresenius Kabi AG, Advanced Pharma, Inc., McGuff Compounding Pharmacy Services, Inc., Central Admixture Pharmacy Services, Inc. (CAPS), Institutional Pharmacy Solutions, LLC, Wedgewood Pharmacy, Medisca Inc., Dougherty's Holdings, Inc., PharMEDium Services, LLC (AmerisourceBergen Corporation), BioScrip, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global compounding chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding chemotherapy market

Global Compounding Chemotherapy Market Detailed Segmentation:

  • By Drug Type:
    • Cytotoxic Drugs
    • Hormonal Agents
    • Immunomodulatory Agents
    • Targeted Therapies
    • Supportive Care Drugs
  • By Compounding Setting:
    • Hospital Compounding
    • Compounding Pharmacies
    • Specialty Clinics
    • Homecare Settings
  • By Route of Administration:
    • Intravenous (IV)
    • Oral
    • Subcutaneous (SC)
    • Intramuscular (IM)
    • Intrathecal (IT)
  • By Patient Type:
    • Adult Patients
    • Pediatric Patients
    • Geriatric Patients
  • By Cancer Type:
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Leukemia
    • Lymphoma
    • Other specific cancer types
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Compounding Method:
    • Aseptic Compounding
    • Non-aseptic Compounding
  • By Packaging Type:
    • Vials
    • Ampoules
    • Pre-filled Syringes
    • Bottles
  • By Regulatory Compliance:
    • USP Chapter <797> Compliance
    • FDA Regulations
    • EMA Regulations
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profile:
    • B.Braun Melsungen AG
    • Fagron NV
    • PharMEDium Services, LLC (AmerisourceBergen Corporation)
    • Baxter International Inc.
    • Fresenius Kabi AG
    • Advanced Pharma, Inc.
    • McGuff Compounding Pharmacy Services, Inc.
    • Central Admixture Pharmacy Services, Inc. (CAPS)
    • Institutional Pharmacy Solutions, LLC
    • Wedgewood Pharmacy
    • Medisca Inc.
    • Dougherty's Holdings, Inc.
    • BioScrip, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Compounding Chemotherapy, By Drug Type
    • Market Compounding Chemotherapy, By Compounding Setting
    • Market Compounding Chemotherapy, By Route of Administration
    • Market Compounding Chemotherapy, By Patient Type
    • Market Compounding Chemotherapy, By Cancer Type
    • Market Compounding Chemotherapy, By Distribution Channel
    • Market Compounding Chemotherapy, By Compounding Method
    • Market Compounding Chemotherapy, By Packaging Type
    • Market Compounding Chemotherapy, By Regulatory Compliance
    • Market Compounding Chemotherapy, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for Personalized Medicine
  • Increasing prevalence of illnesses like cancer
    • Restraints
  • The High cost of compounding chemotherapeutic products
    • Opportunities
  • Rising consumer health benefits from the products
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Compounding Chemotherapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Compounding Chemotherapy Market, By Drug Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cytotoxic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hormonal Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Immunomodulatory Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Targeted Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Supportive Care Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Compounding Chemotherapy Market, By Compounding Setting, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Hospital Compounding
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Compounding Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Homecare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Compounding Chemotherapy Market, By Route of Administration, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Intravenous (IV)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Subcutaneous (SC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Intramuscular (IM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Intrathecal (IT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Compounding Chemotherapy Market, By Patient Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Adult Patients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pediatric Patients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Geriatric Patients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Compounding Chemotherapy Market, By Cancer Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Leukemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other specific cancer types
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Compounding Chemotherapy Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

11. Compounding Chemotherapy Market, By Compounding Method, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Aseptic Compounding
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Non-aseptic Compounding
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

12. Compounding Chemotherapy Market, By Packaging Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Vials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ampoules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pre-filled Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Bottles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

13. Compounding Chemotherapy Market, By Regulatory Compliance, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • USP Chapter <797> Compliance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • FDA Regulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • EMA Regulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

14. Compounding Chemotherapy Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • South Africa
      • Central Africa
      • North Africa

15. Competitive Landscape

  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fagron NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PharMEDium Services, LLC (AmerisourceBergen Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Advanced Pharma, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • McGuff Compounding Pharmacy Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Central Admixture Pharmacy Services, Inc. (CAPS)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Institutional Pharmacy Solutions, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Wedgewood Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medisca Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dougherty's Holdings, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PharMEDium Services, LLC (AmerisourceBergen Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioScrip, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

16. Section

  • Research Methodology
  • About us